Back
Day Range
$104.90
$104.98
52-Week Range
$38.81
$104.98
Volume
21,562,141
50D / 200D Avg
$103.02
/
$74.29
Prev Close
$104.91
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -96.3 | 0.4 |
| P/B | 8.3 | 2.9 |
| ROE % | -8.7 | 3.8 |
| Net Margin % | -6.4 | 3.9 |
| Rev Growth 5Y % | 16.4 | 10.0 |
| D/E | 1.1 | 0.2 |
Analyst Price Target
Hold
$103.18
-1.6%
Low: $85.00
High: $105.00
Forward P/E
582.8
Forward EPS
$0.18
EPS Growth (est.)
+0.0%
Est. Revenue
3.7 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$3.13
$2.82 – $3.28
|
5.1 B | 1 |
| FY2029 |
$2.09
$1.88 – $2.18
|
4.9 B | 1 |
| FY2028 |
$1.74
$0.94 – $2.41
|
4.6 B | 5 |
Key Takeaways
Revenue grew 16.43% annually over 5 years — strong growth
Generating 356.78M in free cash flow
Capital efficient — spends only 4.15% of revenue on capex
Growth
Revenue Growth (5Y)
16.43%
Revenue (1Y)17.69%
Earnings (1Y)N/A
FCF Growth (3Y)234.28%
Quality
Return on Equity
-8.66%
ROIC-1.51%
Net Margin-6.40%
Op. Margin-3.05%
Safety
Debt / Equity
1.05
Current Ratio2.43
Interest Coverage-3.01
Valuation
P/E Ratio
-96.30
P/B Ratio8.34
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 17.69% | Revenue Growth (3Y) | 13.97% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16.43% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 3.25B | Net Income (TTM) | -207.95M |
| ROE | -8.66% | ROA | -3.55% |
| Gross Margin | 69.69% | Operating Margin | -3.05% |
| Net Margin | -6.40% | Free Cash Flow (TTM) | 356.78M |
| ROIC | -1.51% | FCF Growth (3Y) | 234.28% |
| Safety | |||
| Debt / Equity | 1.05 | Current Ratio | 2.43 |
| Interest Coverage | -3.01 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -96.30 | P/B Ratio | 8.34 |
| P/S Ratio | 6.17 | PEG Ratio | 1.15 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 20.03B | Enterprise Value | 21.59B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.25B | 2.76B | 2.50B | 2.08B | 1.77B |
| Net Income | -207.95M | -1.03B | -204.15M | -623.51M | -595.63M |
| EPS (Diluted) | -1.10 | -5.59 | -1.13 | -3.54 | -3.48 |
| Gross Profit | 2.26B | 1.92B | 1.76B | 1.42B | 1.31B |
| Operating Income | -99.08M | -1.05B | -215.01M | -593.51M | -855.68M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5.86B | 5.93B | 6.47B | 6.23B | 6.68B |
| Total Liabilities | 3.46B | 3.53B | 3.33B | 3.18B | 3.30B |
| Shareholders' Equity | 2.40B | 2.40B | 3.15B | 3.04B | 3.39B |
| Total Debt | 2.52B | 2.75B | 2.55B | 2.45B | 2.38B |
| Cash & Equivalents | 956.00M | 600.89M | 605.38M | 242.49M | 315.47M |
| Current Assets | 1.56B | 1.57B | 1.19B | 982.26M | 1.43B |
| Current Liabilities | 641.15M | 732.19M | 514.70M | 412.75M | 517.07M |